Publication:
Celexocib (200 MG/D) or Diclofenac (100 MG/D) in Osteoarthritis: A Multicentre, Double Blind Trial

dc.contributor.authorYazici, H
dc.contributor.authorOzdemir, O
dc.contributor.authorKirazli, Y
dc.contributor.authorOzbek, S
dc.contributor.authorOzerbil, O
dc.contributor.authorGur, A
dc.contributor.authorAral, O
dc.contributor.authorIDUysal, Fusun Guler/0000-0002-4220-0102
dc.contributor.authorIDGur, Ali/0000-0001-9680-6268
dc.contributor.authorIDgilgil, erdal/0000-0002-2763-6223
dc.date.accessioned2020-06-21T15:44:09Z
dc.date.available2020-06-21T15:44:09Z
dc.date.issued2003
dc.departmentOMÜen_US
dc.department-tempCerrahpasa Med Fac, Istanbul, Turkey -- OMEGA, Contract Res Org, Istanbul, Turkey -- Ege Univ, Izmir, Turkey -- Cukurova Univ, Adana, Turkey -- Selcuk Univ, Konya, Turkey -- Dicle Univ, Diyarbakir, Turkey -- Firat Univ, Elazig, Turkeyen_US
dc.descriptionAnnual European Congress of Rheumatology -- JUN 18, 2003 -- LISBON, PORTUGALen_US
dc.description.abstracten_US
dc.identifier.endpage260en_US
dc.identifier.issn0003-4967
dc.identifier.startpage260en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21786
dc.identifier.volume62en_US
dc.identifier.wosWOS:000224551400849
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.journalAnnals of the Rheumatic Diseasesen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCelexocib (200 MG/D) or Diclofenac (100 MG/D) in Osteoarthritis: A Multicentre, Double Blind Trialen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files